In the present study, we focus on TRPV4 and its inhibitors while using memantine/NMDAR and gabapentin/Cav2 channels as comparison, since the two TRPV4 blockers have the most striking protective effects in our studies and have not yet been investigated in mTBI. This evidence concerns the gene TRPV4 and concussion.